Prognostic Impact of CDX2 in Stage II Colon Cancer: Results From Two Nationwide Cohorts

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0285-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Scientific Reports
Multidisciplinary
2016English

Programmed Death Ligand-1 Expression in Stage II Colon Cancer - Experiences From a Nationwide Populationbased Cohort

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

The Prognostic Value of microRNA-126 and Microvessel Density in Patients With Stage II Colon Cancer: Results From a Population Cohort

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Effect of Oncotype DX Colon Cancer Test Results on Treatment Recommendations in Patients With Stage II Colon Cancer: Preliminary Results.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients With Stage II/III Colorectal Cancer

Cancers
Cancer ResearchOncology
2019English

Prognostic Effect of Sidedness in Early Stage Versus Advanced Colon Cancer

Health Science Reports
2018English

Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

Identification of a Sixteen-microRNA Signature as Prognostic Biomarker for Stage II and III Colon Cancer

Oncotarget
Oncology
2017English

Expression of Aquaporin-1 Is a Poor Prognostic Factor for Stage II and III Colon Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy